# Comparison of Optimal Hypertension Regimens

Study · id `cardio:ct-nct02847338` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02847338](<https://clinicaltrials.gov/study/NCT02847338>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02847338

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 940 participants.

## Technical summary

Registry record NCT02847338. Randomized; no masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2023-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 940 participants (enrolled count; ClinicalTrials.gov record NCT02847338, source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)
- Start date: 2016-11 (registry gives no type) (ClinicalTrials.gov record NCT02847338, source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)
- Primary completion: 2023-10 (actual) (ClinicalTrials.gov record NCT02847338, source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)
- Completion: 2023-10 (actual) (ClinicalTrials.gov record NCT02847338, source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02847338, source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02847338-2025-09-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Optimal Hypertension Regimens
- Acronym: AIMHY-INFORM
- Condition: Hypertension
- Intervention (Drug): Amlodipine
- Intervention (Drug): Lisinopril
- Intervention (Drug): Amiloride
- Intervention (Drug): Chlortalidone
- Lead sponsor: Cambridge University Hospitals NHS Foundation Trust
- Lead sponsor class: OTHER
- Collaborator: Medical Research Council
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry intervention name matches this record: Lisinopril (`cardio:lisinopril`)
- Registry intervention name matches this record: Chlorthalidone (`cardio:chlorthalidone`)
- Registry lists this organization as the lead sponsor: Cambridge University Hospitals NHS Foundation Trust (`cardio:org-cambridge-university-hospitals-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: Medical Research Council (United Kingdom) (`cardio:mrc`)

## Provenance

Content hash: 8edadee80592fb36a7ed26c307fd048f4faa0b3d291f49c2e5be7ffdf3368a7f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
